Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MET

Metlife Announces Preferred Stock Dividends

Metlife, Inc. (NYSE: MET) has declared its preferred stock dividends for the third quarter of 2025. The company announced several dividends, including a quarterly dividend of $0.35263005 per share on its floating rate non-cumulative preferred stock, series A (NYSE: MET PRA). Additionally, a semi-annual dividend of $29.375 per share was declared on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, series D, and a quarterly dividend of $351.5625 per share on the 5.625% non-cumulative preferred stock, series E, was announced. The company also declared a quarterly dividend of $296.875 per share on its 4.75% non-cumulative preferred stock, series F. Lastly, a semi-annual dividend of $19.250 per share was declared on the company’s 3.850% fixed rate reset non-cumulative preferred stock, series G.

These dividends are payable on September 15, 2025, to shareholders of record as of Friday, August 29, 2025. It's worth noting that the record date occurred on Sunday, August 31, 2025.

Metlife, Inc., founded in 1868, is a leading financial services company with operations in more than 40 markets globally, holding leading positions in the United States, Asia, Latin America, Europe, and the Middle East. Following these announcements, the company's shares moved -0.76%, and are now trading at a price of $77.33. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS